Michael J Astrue - Net Worth and Insider Trading
Michael J Astrue Net Worth
The estimated net worth of Michael J Astrue is at least $400,117 dollars as of 2024-04-16. Michael J Astrue is the Director of Arqule Inc and owns about 20,000 shares of Arqule Inc (ARQL) stock worth over $400,000. Michael J Astrue is also the Director of VIVUS Inc and owns about 1,000 shares of VIVUS Inc (VVUSQ) stock worth over $117. Details can be seen in Michael J Astrue's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael J Astrue has not made any transactions after 2013-09-04 and currently still holds the listed stock(s).
Transaction Summary of Michael J Astrue
Michael J Astrue Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael J Astrue owns 3 companies in total, including InVivo Therapeutics Holdings Corp (NVIVQ) , VIVUS Inc (VVUSQ) , and Arqule Inc (ARQL) .
Click here to see the complete history of Michael J Astrue’s form 4 insider trades.
Insider Ownership Summary of Michael J Astrue
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NVIVQ | InVivo Therapeutics Holdings Corp | 2013-08-22 | Interim CEO |
| VVUSQ | VIVUS Inc | 2013-09-04 | director |
| ARQL | Arqule Inc | 2006-05-18 | director |
Michael J Astrue Latest Holdings Summary
Michael J Astrue currently owns a total of 2 stocks. Among these stocks, Michael J Astrue owns 20,000 shares of Arqule Inc (ARQL) as of May 24, 2005, with a value of $400,000 and a weighting of 99.97%. Michael J Astrue also owns 1,000 shares of VIVUS Inc (VVUSQ) as of September 4, 2013, with a value of $117 and a weighting of 0.03%.
Latest Holdings of Michael J Astrue
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARQL | Arqule Inc | 2005-05-24 | 20,000 | 20.00 | 400,000 |
| VVUSQ | VIVUS Inc | 2013-09-04 | 1,000 | 0.12 | 117 |
Holding Weightings of Michael J Astrue
Michael J Astrue Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael J Astrue has made a total of 0 transactions in Arqule Inc (ARQL) over the past 5 years. The most-recent trade in Arqule Inc is the acquisition of 20,000 shares on May 24, 2005, which cost Michael J Astrue around $124,200.
According to the SEC Form 4 filings, Michael J Astrue has made a total of 0 transactions in VIVUS Inc (VVUSQ) over the past 5 years. The most-recent trade in VIVUS Inc is the acquisition of 1,000 shares on September 4, 2013, which cost Michael J Astrue around $119,600.
Insider Trading History of Michael J Astrue
- 1
Michael J Astrue Trading Performance
GuruFocus tracks the stock performance after each of Michael J Astrue's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael J Astrue is -2.24%. GuruFocus also compares Michael J Astrue's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael J Astrue within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael J Astrue's insider trading performs compared to the benchmark.
Performance of Michael J Astrue
Average Relative Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Relative Return(%) | -1.48 | -2.24 | -20.8 | -41.24 | -24.29 | -34.9 |
| Relative Return to S&P 500(%) | -2.5 | -7.11 | -30.47 | -54.36 | -34.38 | -42.16 |
Michael J Astrue Ownership Network
Ownership Network List of Michael J Astrue
Ownership Network Relation of Michael J Astrue
Michael J Astrue Owned Company Details
What does InVivo Therapeutics Holdings Corp do?
Who are the key executives at InVivo Therapeutics Holdings Corp?
Michael J Astrue is the Interim CEO of InVivo Therapeutics Holdings Corp. Other key executives at InVivo Therapeutics Holdings Corp include 10 percent owner Brice Foose , Chief Financial Officer Richard Christopher , and director & CEO and CMO Richard M. Toselli .
InVivo Therapeutics Holdings Corp (NVIVQ) Insider Trades Summary
Over the past 18 months, Michael J Astrue made no insider transaction in InVivo Therapeutics Holdings Corp (NVIVQ). Other recent insider transactions involving InVivo Therapeutics Holdings Corp (NVIVQ) include a net sale of 330,000 shares made by Brice Foose ,
In summary, during the past 3 months, insiders sold 0 shares of InVivo Therapeutics Holdings Corp (NVIVQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 330,000 shares of InVivo Therapeutics Holdings Corp (NVIVQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 330,000 shares.
InVivo Therapeutics Holdings Corp (NVIVQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
InVivo Therapeutics Holdings Corp Insider Transactions
Michael J Astrue Mailing Address
Above is the net worth, insider trading, and ownership report for Michael J Astrue. You might contact Michael J Astrue via mailing address: C/o Transkaryotic Therapies Inc, 700 Main Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
